Skip to content
Menu

Merit Medical Systems, Inc. MMSI

Full chart Compare
Set alert

Price alert · MMSI

All alert types
84.49 USD +0.08 (+0.09%)

As ofNov 20, 2026, 12:39 PM EST

84.20 Day range 86.20
59.74 52-week range 94.85
YTD
-4.14%
1 year
-0.46%

5D -2.54 (-2.92%)

84858687FriMonTueWedThu84.41
Market cap
5.06B
Revenue (ttm)
1.61B
Profit margin
9.94%
EPS (ttm)
2.67
Shares out
59.92M
P/E ratio
31.62
Forward P/E
18.08
YTD return
-4.14%
1-year return
-0.46%
50-day average
87.87
Volume
153.03K
Avg volume
654.43K
Open
84.58
Previous close
84.41
Day's range
84.20 – 86.20
52-week range
59.74 – 94.85
Beta
0.55
Analysts
Buy
Price target
107.00 (+26.6%)
Earnings date
Feb 23, 2027

Key statistics

200-day average
77.29
Enterprise value
5.47B
PEG ratio
1.53
Price / sales
3.14
Price / book
2.90
Revenue growth
8.40%
Free cash flow
166.63M
Total cash
503.55M
Total debt
822.06M
Return on equity
9.78%
Short % of float
9.01%

Fundamental scorecard

18 of 25 checks passed on MMSI’s reported financials

ValueGrowthProfitabilityHealthDividend

18of 25 checks passed

  • Value 4 of 5
  • Growth 5 of 5
  • Profitability 4 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
MMSI Revenue — quarterly 416.24M
MMSI Net income — quarterly 42.31M
MMSI EPS — quarterly 0.71

Earnings

MMSI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 30, 20261.11———
Oct 29, 2026Sep 30, 20261.041.12+0.08+7.69%
Jul 30, 2026Jun 30, 20260.9591.19+0.23+24.09%
Apr 30, 2026Mar 31, 20260.840.94+0.10+11.90%
Feb 24, 2026Dec 31, 20250.961.04+0.08+8.33%
Oct 30, 2025Sep 30, 20250.820.92+0.10+12.20%

Upgrades / downgrades

MMSI analyst upgrades and downgrades
DateFirmActionFromTo
Nov 12, 2026Freedom Capital MarketsmainHoldHold
Oct 30, 2026Canaccord GenuitymainBuyBuy
Oct 30, 2026JP MorganmainOverweightOverweight
Oct 30, 2026Wells FargomainEqual-WeightEqual-Weight
Oct 30, 2026NeedhammainBuyBuy
Oct 30, 2026BTIGmainBuyBuy

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
merit.com

News

Your note

Sign in to keep a note on MMSI — it syncs with the Stock Master app.

Insider holders

MMSI insider holders
InsiderRelationLatest transactionDateShares held
ARONSON MARTHA GOLDBERGChief Executive OfficerPurchaseMay 5, 202649,792
CARPENTER LONNY JDirectorStock Award(Grant)May 17, 202620,824
GUNDERSON THOMAS JAMESDirectorConversion of Exercise of derivative securityMay 19, 202660,741
LAMPROPOULOS FRED POfficer and DirectorSaleNov 24, 20251,126,460
LLOYD BRIAN GOfficerSaleNov 15, 202662,132
MILLNER F ANNDirectorStock Award(Grant)May 17, 202638,000

Institution ownership

MMSI institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.84%9,492,223801.24MSep 29, 2026
Vanguard Portfolio Management LLC5.71%3,422,076288.86MSep 29, 2026
Vanguard Capital Management LLC4.32%2,591,018218.71MSep 29, 2026
State Street Corporation4.10%2,457,916207.47MSep 29, 2026
Fuller & Thaler Asset Management Inc.3.60%2,155,047181.91MSep 29, 2026
Dimensional Fund Advisors LP2.76%1,655,196139.72MSep 29, 2026

Fund ownership

MMSI fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.94%3,556,402300.20MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,802,360152.14MJun 29, 2026
Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund2.58%1,543,773130.31MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.57%1,542,648130.21MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.17%1,299,239109.67MJun 29, 2026
Conestoga Funds-Conestoga Small Cap Fund1.60%958,07580.87MJun 29, 2026